Heini, A.D.; Bacher, U.; Porret, N.; Wiedemann, G.; Legros, M.; Stalder Zeerleder, D.; Seipel, K.; Novak, U.; Daskalakis, M.; Pabst, T.
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells 2022, 11, 2747.
https://doi.org/10.3390/cells11172747
AMA Style
Heini AD, Bacher U, Porret N, Wiedemann G, Legros M, Stalder Zeerleder D, Seipel K, Novak U, Daskalakis M, Pabst T.
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells. 2022; 11(17):2747.
https://doi.org/10.3390/cells11172747
Chicago/Turabian Style
Heini, Alexander D., Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, and Thomas Pabst.
2022. "Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma" Cells 11, no. 17: 2747.
https://doi.org/10.3390/cells11172747
APA Style
Heini, A. D., Bacher, U., Porret, N., Wiedemann, G., Legros, M., Stalder Zeerleder, D., Seipel, K., Novak, U., Daskalakis, M., & Pabst, T.
(2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17), 2747.
https://doi.org/10.3390/cells11172747